Medical Journals

Non-psychoactive Cb2 Cannabinoid Agonists Stimulate Neural Progenitor Proliferation.

Authors:
  • Palazuelos Javier
  • Aguado Tania
  • Egia Ainara
  • Mechoulam Raphael
  • Guzmán Manuel
  • Galve-Roperh Ismael

From: Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University, 28040 Madrid, Spain.

The FASEB journal : official publication of the Federation of American Societies for Experimental Biology

  • Publish Date: Nov 2006
  • ISSN: 1530-6860
  • Volume: 20
  • Issue: 13
  • Pages: 2405-7
  • Medium: Internet
  • Language: English
  • Citation (JAMA): Palazuelos Javier, Aguado Tania, Egia Ainara, et al. Non-psychoactive Cb2 Cannabinoid Agonists Stimulate Neural Progenitor Proliferation.. FASEB J. Nov 2006;20:2405-7

Abstract

Cannabinoids, the active components of marijuana and their endogenous counterparts, act on the brain and many other organs through the widely expressed CB1 cannabinoid receptor. In contrast, the CB2 cannabinoid receptor is abundant in the immune system and shows a restricted expression pattern in brain cells. CB2-selective agonists are, therefore, very attractive therapeutic agents as they do not cause CB1-mediated psychoactive effects. CB2 receptor expression in brain has been partially examined in differentiated cells, while its presence and function in neural progenitor cells remain unknown. Here we show that the CB2 receptor is expressed, both in vitro and in vivo, in neural progenitors from late embryonic stages to adult brain. Selective pharmacological activation of the CB2 receptor in vitro promotes neural progenitor cell proliferation and neurosphere generation, an action that is impaired in CB2-deficient cells. Accordingly, in vivo experiments evidence that hippocampal progenitor proliferation is increased by administration of the CB2-selective agonist HU-308. Moreover, impaired progenitor proliferation was observed in CB2-deficient mice both in normal conditions and on kainate-induced excitotoxicity. These findings provide a novel physiological role for the CB2 cannabinoid receptor and open a novel therapeutic avenue for manipulating neural progenitor cell fate.

Mesh Headings (Keywords): Animals, Cannabinoids, Cell Differentiation, DNA Primers, Embryo, Mammalian, Hippocampus, Humans, Kainic Acid, Mice, Mice, Knockout, Neurons, Receptor, Cannabinoid, CB2, Reverse Transcriptase Polymerase Chain Reaction, Stem Cells


Check for Full Text / PubMed Unique Identifier (PMID): 17015409


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.